EUDA Health Holdings (EUDA) Ratios
EUDA Health Holdings Ratios
EUDA's free cash flow for Q2 2026 was $-603.02K. For the 2026 fiscal year, EUDA's free cash flow was increased by $0.00 and operating cash flow was $-603.02K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.18 | 0.18 | 0.08 | 0.86 | 0.59 |
| Quick Ratio | 0.18 | 0.15 | 0.08 | 0.84 | 0.59 |
| Cash Ratio | 0.06 | 0.06 | 0.02 | 0.00 | 0.03 |
| Solvency Ratio | -0.40 | -3.53 | -1.13 | -0.85 | 0.15 |
| Operating Cash Flow Ratio | -0.42 | -0.49 | -0.33 | -0.05 | 0.06 |
| Short-Term Operating Cash Flow Coverage | -1.10 | -1.95 | -0.92 | -0.43 | 1.25 |
| Net Current Asset Value | $ -4.94M | $ -3.54M | $ -8.07M | $ -4.11M | $ -3.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.40 | 0.74 | 2.57 | 0.14 | 0.06 |
| Debt-to-Equity Ratio | -0.56 | -0.50 | -0.45 | -1.03 | 0.89 |
| Debt-to-Capital Ratio | -1.30 | -0.99 | -0.82 | 32.89 | 0.47 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.40 | -0.68 | -0.17 | -7.28 | 15.35 |
| Debt Service Coverage Ratio | -0.88 | -16.03 | -2.60 | -6.69 | 2.69 |
| Interest Coverage Ratio | -10.67 | -386.17 | -170.55 | -60.98 | -4.41 |
| Debt to Market Cap | 0.03 | 0.01 | 0.08 | 0.18 | 0.00 |
| Interest Debt Per Share | 1.42 | 0.81 | 0.12 | 0.31 | 0.06 |
| Net Debt to EBITDA | -0.98 | -0.06 | -0.38 | -0.15 | 0.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.88% | 19.00% | 22.72% | 23.11% | 27.42% |
| EBIT Margin | -36.61% | -438.72% | -226.94% | -659.13% | 23.60% |
| EBITDA Margin | -30.65% | -434.41% | -223.94% | -652.33% | 29.39% |
| Operating Profit Margin | -35.78% | -432.19% | -106.87% | -151.93% | -12.28% |
| Pretax Profit Margin | -39.97% | -439.85% | -227.57% | -662.32% | 36.62% |
| Net Profit Margin | -40.65% | -382.87% | -270.86% | -661.06% | 18.97% |
| Continuous Operations Profit Margin | -40.58% | -439.74% | -227.57% | -664.34% | 35.60% |
| Net Income Per EBT | 101.72% | 87.05% | 119.02% | 99.81% | 51.81% |
| EBT Per EBIT | 111.69% | 101.77% | 212.94% | 435.94% | -298.10% |
| Return on Assets (ROA) | -161.53% | -887.69% | -766.08% | -97.09% | 10.81% |
| Return on Equity (ROE) | 65.17% | 601.53% | 133.89% | 706.83% | 165.92% |
| Return on Capital Employed (ROCE) | 59.25% | 719.00% | 53.48% | 163.78% | -81.99% |
| Return on Invested Capital (ROIC) | 136.72% | 1457.08% | 96.44% | -4613.23% | -48.97% |
| Return on Tangible Assets | -178.30% | -1102.67% | -766.08% | -97.09% | 12.88% |
| Earnings Yield | -3.23% | -10.58% | -25.77% | -125.54% | 0.96% |
| Efficiency Ratios | |||||
| Receivables Turnover | 20.41 | 23.56 | 15.50 | 19.52 | 1.11 |
| Payables Turnover | 270.55 | 125.52 | 2222.17 | 1.98 | 1.17 |
| Inventory Turnover | 1345.80 | 25.19 | 0.00 | 4.47 | 0.00 |
| Fixed Asset Turnover | 20.52 | 12.68 | 17.91 | 30.24 | 28.29 |
| Asset Turnover | 3.97 | 2.32 | 2.83 | 0.15 | 0.57 |
| Working Capital Turnover Ratio | -1.67 | -0.71 | -0.61 | -1.07 | -1.90 |
| Cash Conversion Cycle | 16.81 | 27.08 | 23.39 | -83.87 | 16.35 |
| Days of Sales Outstanding | 17.89 | 15.49 | 23.55 | 18.70 | 327.35 |
| Days of Inventory Outstanding | 0.27 | 14.49 | 0.00 | 81.74 | 0.00 |
| Days of Payables Outstanding | 1.35 | 2.91 | 0.16 | 184.30 | 311.01 |
| Operating Cycle | 18.16 | 29.98 | 23.55 | 100.44 | 327.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.31 | -1.25 | -0.11 | -0.13 | 0.05 |
| Free Cash Flow Per Share | -1.36 | -1.33 | -0.11 | -0.13 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | -23.23 | -17.54 | -583580.34 | -84.18 | 226.84 |
| Capital Expenditure Coverage Ratio | -23.23 | -17.54 | -583580.34 | -84.18 | 226.84 |
| Operating Cash Flow Coverage Ratio | -1.01 | -1.60 | -0.86 | -0.42 | 0.96 |
| Operating Cash Flow to Sales Ratio | -0.36 | -0.51 | -0.79 | -0.41 | 0.10 |
| Free Cash Flow Yield | -2.95% | -1.48% | -7.49% | -7.79% | 0.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -31.01 | -9.51 | -3.88 | -0.80 | 104.32 |
| Price-to-Sales (P/S) Ratio | 12.58 | 36.17 | 10.51 | 5.27 | 19.79 |
| Price-to-Book (P/B) Ratio | -20.17 | -56.83 | -5.20 | -5.63 | 173.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -33.91 | -67.46 | -13.35 | -12.83 | 204.13 |
| Price-to-Operating Cash Flow Ratio | -35.37 | -71.31 | -13.35 | -12.98 | 203.23 |
| Price-to-Earnings Growth (PEG) Ratio | 0.37 | -0.35 | 0.05 | 0.00 | 0.35 |
| Enterprise Value Multiple | -42.04 | -8.39 | -5.08 | -0.95 | 67.54 |
| Enterprise Value | 87.89M | 146.13M | 42.15M | 23.39M | 90.49M |
| EV to EBITDA | -42.04 | -8.39 | -5.08 | -0.95 | 67.54 |
| EV to Sales | 12.89 | 36.43 | 11.37 | 6.21 | 19.85 |
| EV to Free Cash Flow | -34.72 | -67.94 | -14.44 | -15.14 | 204.75 |
| EV to Operating Cash Flow | -36.22 | -71.82 | -14.44 | -15.32 | 203.85 |
| Tangible Book Value Per Share | -2.38 | -1.79 | -0.27 | -0.29 | -0.07 |
| Shareholders’ Equity Per Share | -2.29 | -1.57 | -0.28 | -0.29 | 0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | 0.00 | 0.00 | 0.00 | 0.03 |
| Revenue Per Share | 3.67 | 2.47 | 0.14 | 0.31 | 0.49 |
| Net Income Per Share | -1.49 | -9.46 | -0.37 | -2.07 | 0.09 |
| Tax Burden | 1.02 | 0.87 | 1.19 | 1.00 | 0.52 |
| Interest Burden | 1.09 | 1.00 | 1.00 | 1.00 | 1.55 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| SG&A to Revenue | 0.80 | 0.83 | 1.15 | 1.54 | 0.32 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.88 | 0.12 | 0.35 | 0.06 | 0.49 |
Currency in USD